血清维生素D水平对卵巢储备标志物的影响:一项前瞻性横断面研究
本研究为布鲁塞尔大学医院生殖医学中心开展的前瞻性横断面研究,纳入283例小于42岁、首次接受治疗周期的不孕女性,在同一天检测血清AMH与25-OH维生素D,并于月经第2或第3天测量窦卵泡计数(AFC)。结果显示维生素D缺乏组与正常组的AMH和AFC均无显著差异,25-OH维生素D与AMH或AFC亦无相关性,调整混杂因素后仍无显著关联。
要点
- 283例不孕女性中30.7%(n=87)维生素D缺乏(<20 ng/mL),69.3%(n=196)维生素D正常(≥20 ng/mL)。
- 维生素D缺乏组与正常组的AMH为3.9 μ/L(±3.8)对4.3 μ/L(±4.8),P=0.5,无显著差异。
- 维生素D缺乏组与正常组的AFC为13.9(±13.3)对12.7(±11.4),P=0.7,无显著差异。
核心结论
- 在不孕女性中,维生素D与卵巢储备标志物AMH和AFC无关联。
- 作者认为维生素D缺乏对卵巢储备产生不利影响的可能性极低。
研究设计与样本
- 研究为布鲁塞尔大学医院生殖医学中心开展的前瞻性横断面研究,研究时长为一年。
- 共纳入283例连续的不孕女性,年龄小于42岁,均为在本机构接受首次治疗周期者。
- 所有患者在开始不孕治疗前、于研究启动后12个月的时间区间内被招募。
- 排除服用维生素D补充剂、因系统性疾病服药或曾接受卵巢手术的女性。
- 所有不孕女性的血清AMH与维生素D于同一天采样;AFC在采血后第一个周期的第2或第3天测量。
主要发现
- 全部患者中30.7%(n=87)为维生素D缺乏(<20 ng/mL),69.3%(n=196)为维生素D正常(≥20 ng/mL)。
- 两组平均AMH水平无显著差异:维生素D缺乏组3.9 μ/L(±3.8)对维生素D正常组4.3 μ/L(±4.8),P=0.5。
- 两组平均AFC无显著差异:维生素D缺乏组13.9(±13.3)对维生素D正常组12.7(±11.4),P=0.7。
- 25-OH维生素D与AMH无相关性(Spearman r=0.02,P=0.7),与AFC亦无相关性(Spearman r=-0.02,P=0.7)。
- 调整年龄、BMI、吸烟状态、不孕原因和采血季节后,总25OH-D预测log10 AMH的回归斜率为0.006(标准误SE=0.07,P=0.9);AFC与维生素D的回归系数为-0.09(SE=0.08,P=0.2),均无显著关联。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文指出,尽管这是首个评估维生素D与最重要卵巢储备标志物(AMH和AFC)关系的前瞻性研究,但用于产生研究结果的数据本质上是横断面的。
- 原文指出,因此无法生成或排除任何因果效应假设。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is there any association between serum 25-OH vitamin D levels and ovarian reserve markers in infertile women? SUMMARY ANSWER: Vitamin D is not associated with the ovarian reserve markers, anti-mullerian hormone (AMH) and antral follicle count (AFC), in infertile women. WHAT IS KNOWN ALREADY: The mechanism underlying the relationship between vitamin D deficiency and reproduction is still unclear; however, evidence indicates a potential direct negative impact on ovarian function. This is mainly due to the fact that gonadal function may be altered by vitamin D deficiency, as observed by the expression of vitamin D receptor mRNA in human ovaries, mixed ovarian cell cultures and granulosa cell cultures. On the other hand, results from clinical studies are conflicting, with some suggesting that vitamin D status is associated with ovarian reserve, whereas other cross-sectional studies have not found any significant correlation between vitamin D and AMH levels. STUDY DESIGN, SIZE, DURATION: This study was a prospective cross-sectional study from the Centre for Reproductive Medicine at the University Hospital of Brussels. The duration of the study was one year. PARTICIPANTS/MATERIALS, SETTING, METHODS: Overall, the study included 283 consecutive infertile women younger than 42 years old and undergoing their first treatment cycle in our institution. All patients were recruited within a time interval of 12 months from the initiation of the study, before undergoing infertility treatment. Women consuming vitamin D supplements or taking medication for systematic disease or women who had undergone ovarian surgery were excluded from the study. All infertile women had serum AMH and vitamin D sampled on the same day. AFC was measured on the second or third day of the first cycle following the blood sampling for the determination of AMH and 25-OH vitamin D levels. MAIN RESULTS AND THE ROLE OF CHANCE: Among all patients, 30.7% (n = 87) were vitamin D deficient (<20 ng/mL) whereas 69.3% (n = 196) had normal vitamin D levels (≥20 ng/mL). The mean AMH and AFC levels did not differ significantly between the two groups: AMH 3.9 μ/L (±3.8) versus 4.3 μ/L (±4.8), (P value = 0.5) and AFC 13.9 (±13.3) versus 12.7 (±11.4), (P = 0.7), respectively. No correlation was observed between 25-O H vitamin D and AMH (spearman's r = 0.02, P value = 0.7) or AFC (spearman's r = -0.02, P value = 0.7). In multiple linear regression analysis, after adjusting for potential confounders (age, BMI, smoking status, infertility cause and season of blood sampling), the regression slope in all participants for total 25OH-D predicting log10 AMH was 0.006 [standard error (SE) = 0.07, P value = 0.9]. Similarly, no significant association was observed between AFC and vitamin D levels, even after controlling for relevant co-variants (regression coefficient -0.09. SE 0.08, P value = 0.2). LIMITATIONS, REASONS FOR CAUTION: Although this is the first prospective study to evaluate the relationship between vitamin D and the most important ovarian reserve markers (AMH and AFC), we need to acknowledge that the data used to generate the study findings are cross-sectional in nature. In this regard, we cannot generate or exclude any causal effect hypothesis. Nevertheless, our data support that an association between vitamin D and ovarian reserve markers is highly unlikely to exist. WIDER IMPLICATIONS OF THE FINDINGS: Although data from basic research indicate that vitamin D deficiency may have an effect on steroidogenesis and follicular development, our study, by prospectively recruiting a large number of infertile women, clearly demonstrates that vitamin D deficiency is highly unlikely to have a detrimental effect on ovarian reserve. Ongoing prospective and translational research projects are currently being conducted in order to evaluate the potential effect of vitamin D deficiency on reproductive outcome mediated through either an effect on the oocyte quality or on endometrial receptivity and embryo implantation. STUDY FUNDING/COMPETING INTERESTS: No external funding was used for this study. No conflicts of interest are declared. TRIAL REGISTRATION NUMBER: N/A.
引用
- Drakopoulos P, van de Vijver A, Schutyser V, et al. The effect of serum vitamin D levels on ovarian reserve markers: a prospective cross-sectional study. Hum Reprod. 2016. PMID: 27927849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。